AWE
BSX icon

Avidian Wealth Enterprises’s Boston Scientific BSX Stock Holding History

Avidian Wealth Enterprises’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Buy
6,650
+393
+6% +$21.3K 0.01% 610
2026
Q1 		$393K Buy
6,257
+694
+12% +$55.5K 0.01% 487
2025
Q4 		$530K Buy
5,563
+1,727
+45% +$169K 0.02% 359
2025
Q3 		$375K Buy
3,836
+433
+13% +$44.8K 0.01% 425
2025
Q2 		$366K Buy
3,403
+190
+6% +$19.2K 0.01% 402
2025
Q1 		$324K Buy
3,213
+90
+3% +$9.06K 0.01% 397
2024
Q4 		$279K Sell
3,123
-1,590
-34% -$140K 0.01% 415
2024
Q3 		$395K Buy
4,713
+269
+6% +$21.2K 0.02% 340
2024
Q2 		$342K Buy
4,444
+855
+24% +$62.6K 0.01% 366
2024
Q1 		$246K Buy
+3,589
New +$231K 0.01% 388
2022
Q1 		– Sell
-9,018
Closed -$383K – 500
2021
Q4 		$383K Buy
+9,018
New +$379K 0.02% 353

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Avidian Wealth Enterprises's BSX Position: Q2 2026 in Review

Avidian Wealth Enterprises increased its Boston Scientific (BSX) stake by 6.3% in Q2 2026, buying an estimated $21.3K and bringing the position to 6,650 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #610.

Avidian Wealth Enterprises first reported a position in BSX in Q4 2021 and has held it in 11 quarters since. The position peaked at $530K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Avidian Wealth Enterprises held 6,650 shares of Boston Scientific worth $284K as of Q2 2026.
  • Avidian Wealth Enterprises bought 393 Boston Scientific shares in Q2 2026, an estimated $21.3K.
  • Boston Scientific made up 0.01% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #610 holding.
  • Avidian Wealth Enterprises first reported a position in Boston Scientific in Q4 2021 and has held it in 11 quarters since.
  • Avidian Wealth Enterprises's Boston Scientific position peaked at $530K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.